Cargando…

Antibody response to the messenger RNA corona virus disease 2019 vaccine in liver transplant recipients

Detalles Bibliográficos
Autores principales:	Mungmunpuntipantip, Rujittika, Wiwanitkit, Viroj
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110953/ https://www.ncbi.nlm.nih.gov/pubmed/35481669 http://dx.doi.org/10.1002/hep4.1977

Ejemplares similares

Messenger RNA vaccines and neutralizing anti–severe acute respiratory syndrome coronavirus 2 antibodies in patients with immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

COVID-19 vaccination and lung transplant recipients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Kidney Transplant Recipients With COVID-19 and Monoclonal Antibody Therapy: Additional Considerations
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

CoronaVac or BNT162b2 Vaccine as a Third Dose
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Aseptic Meningitis and mRNA Coronavirus Disease 2019 Vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Antibody response to coronavirus disease 2019 vaccines after allergic reaction to first dose: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Split-dosing of coronavirus disease 2019 vaccines
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on “Heterologous adenovirus‐vector/messenger RNA regimen, humoral response and liver transplant recipients”
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Serological response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 prime-boost vaccination”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

SARS CoV-2 vaccine AND rituximab. Comment on: “SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response” by Verhoeven Joint Bone Spine. 2021;88:105258
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Response to case report on myocarditis and pericarditis after COVID‐19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Comment on “Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Venous sinus thrombosis after the second dose of SARS-CoV-2 vaccine administration
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Healthcare professionals & adverse events of ChAdOx1 nCoV-19 coronavirus vaccine
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

COVID-19 reinfection in a kidney transplant recipient
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on “Arthritis due to monkeypox virus: A case report” by Lombès A et al. Joint Bone Spine. 2023;90:105492
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Comment on immunity to COVID-19 vaccination in patients with liver disease and transplant recipients
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Disease profile and patient outcomes in vaccinated COVID-19 patients
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Uncertainty in using chest computed tomography in early coronavirus disease (COVID-19)
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2020)

Perinatal outcomes of pregnant women with COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Correspondence on “Does wearing double surgical masks during the COVID-19 pandemic and maternal oxygen saturation in term pregnant women”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Letter on the article “Long-COVID: Cognitive deficits (brain fog) and brain lesions in non—hospitalized patients”
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Comment on Fetal Gestational Age Determination Using Ultrasound Placental Thickness
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Ruxolitinib and Severe COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

COVID-19–Associated Immune Thrombocytopenia in a Toddler: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Monkeypox in HIV Infected Cases: A Summary on Clinical Presentation of 27 Cases
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Regdanvimab Treatment of COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Guillain–Barré Syndrome with Normal Nerve Conduction Study Associated with COVID-19 Infection in a Child: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Vitamin D deficiency and vitamin D receptor FokI polymorphism as risk factors for COVID-19: correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

COVID-19 pandemic and tetanus situation: Observation from tropical areas
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Denial of and disbelief in COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Long COVID in Children up to 12 y of Age – A Retrospective Telephonic Survey: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Melioidosis amid COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2023)

Reply to: "The spoils of war and the long-term spoiling of health conditions of entire nations"
por: Keebayoon, Amnuay, et al.
Publicado: (2022)

Mortality-related immune features and COVID-19
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Correspondence on “Immune thrombocytopenia in 2 healthy young women after the Pfizer‐BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination”
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ffpsjh66u3lk9dbaf8t8l29or1